NDC Package 23155-686-31 Octreotide Acetate

Injection, Solution Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
23155-686-31
Package Description:
5 mL in 1 VIAL, GLASS
Product Code:
Proprietary Name:
Octreotide Acetate
Non-Proprietary Name:
Octreotide Acetate
Substance Name:
Octreotide Acetate
Usage Information:
Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (such as carcinoid tumors, vasoactive intestinal peptide tumors) that are found usually in the intestines and pancreas. The symptoms occur when these tumors make too much of certain natural substances (hormones). This medication works by blocking the production of these hormones. By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals. Octreotide is also used to treat a certain condition (acromegaly) that occurs when the body makes too much of a certain natural substance called growth hormone. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Octreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for these conditions. This medication is usually used with other treatment (such as surgery, radiation, other drugs).
11-Digit NDC Billing Format:
23155068631
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
5 ML
NDC to RxNorm Crosswalk:
  • RxCUI: 312068 - octreotide 50 MCG in 1 ML Injection
  • RxCUI: 312068 - 1 ML octreotide 0.05 MG/ML Injection
  • RxCUI: 312068 - octreotide 50 MCG per 1 ML Injection
  • RxCUI: 312069 - octreotide 100 MCG in 1 ML Injection
  • RxCUI: 312069 - 1 ML octreotide 0.1 MG/ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA203765
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-25-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 23155-686-31 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    23155068631J2354Octreotide inj, non-depot25 MCG51200200

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 23155-686-31?

    The NDC Packaged Code 23155-686-31 is assigned to a package of 5 ml in 1 vial, glass of Octreotide Acetate, a human prescription drug labeled by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. The product's dosage form is injection, solution and is administered via intravenous; subcutaneous form.This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package.

    Is NDC 23155-686 included in the NDC Directory?

    Yes, Octreotide Acetate with product code 23155-686 is active and included in the NDC Directory. The product was first marketed by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. on May 25, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 23155-686-31?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume. The calculated billable units for this package is 5.

    What is the 11-digit format for NDC 23155-686-31?

    The 11-digit format is 23155068631. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-223155-686-315-4-223155-0686-31